Fig. 5From: High expression of p62/SQSTM1 predicts shorter survival for patients with pancreatic cancerKaplan–Meier disease-specific survival (DSS) curves and univariable Cox proportional hazard analyses for patients with low, intermediate and high tumor cell expression of p62. A 2-year survival among the 3 groups. B 5-year survival among the 3 groupsBack to article page